Skip to main content
  • 1412 Accesses

Abstrait

Ľincidence des hémopathies augmente depuis deux décennies. Ainsi ľincidence des lymphomes est passée, entre 1980 et 2000, de 7 à 15 nouveaux cas pour 100 000 habitants et par an. Les méthodes diagnostiques sont de plus en plus performantes. Le pronostic de ces hémopathies s’est considérablement amélioré et ľinvestissement thérapeutique est donc de plus en plus important. Enfin, le vieillissement de la population entraîne ľémergence de nouvelles hémopathies malignes, comme les syndromes myéloprolifératifs. De nombreux facteurs contribuent donc à ľaugmentation ďincidence des hémopathies malignes, et tout, contribue à ce qu’elles soient traitées de façon plus agressive avec un espoir de rémission complète beaucoup plus important. Les lignes de chimiothérapie peuvent se succéder pour maintenir la rémission, chez des patients de plus en plus âgés, et dont ľétat général peut s’être altéré au cours des traitements.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Raynard B, Nitenberg G, Gory-Delabaere G, et al. (2002) Standards, options et recommandations pour la nutrition artificielle au cours et au décours des greffes de cellules souches hématopoïétiques. Bull Cancer 89: 381–98

    PubMed  Google Scholar 

  2. Raynard B, Nitenberg G, Gory-Delabaere G, et al. (2003) Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002). Br J Cancer 89 Suppl 1: S101–6

    Article  PubMed  Google Scholar 

  3. Muscaritoli M, Grieco G, Capria S, et al. (2002) Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 75: 182–90

    Google Scholar 

  4. Murray SM, Pindoria S, (2002) Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev (2): CD002920

    Google Scholar 

  5. Dewys WD, Begg C, Lavin PT, et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491–7

    Article  PubMed  CAS  Google Scholar 

  6. Rossignol G, Meuric J, Dupoiron D, et al. (2005) Prévalence et dépistage de la dénutrition en cancérologie. Nutr Clin Metabol 19 (suppl 1): S73

    Google Scholar 

  7. Deeg HJ, Seidel K, Bruemmer B, et al. (1995) Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 15: 461–8

    PubMed  CAS  Google Scholar 

  8. Iestra JA, Fibbe WE, Zwinderman AH, et al. (1999) Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant 23: 933–9

    Article  PubMed  CAS  Google Scholar 

  9. Iestra JA, Fibbe WE, Zwinderman AH, et al. (2002) Body weight recovery, eating difficultiers and compliance with dietary advice in the first year after stem cell transplantation: a prospective study. Bone Marrow Transplant 29: 417–24

    Article  PubMed  CAS  Google Scholar 

  10. Schulte C, Reinhardt W, Beelen D, et al. (1998) Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Transplant 22: 1171–8

    Article  PubMed  CAS  Google Scholar 

  11. Trikha M, Corringham R, Klein B, Rossi JF, (2003) Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer. A Review of the Rationale, and Clinical Evidence. Clin Cancer Res 9: 4653–65

    PubMed  CAS  Google Scholar 

  12. Hungria VT, Brandizil LI, Chiattone CS, et al. (1999) Metabolism of an artificial emulsion resembling chylomicrons in patients with multiple myeloma. Leuk Res. 23: 637–41

    Article  PubMed  CAS  Google Scholar 

  13. Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104: 3009–20

    Article  PubMed  CAS  Google Scholar 

  14. Goncalves RP, Hungria VT, Chiattone CS, et al. (2003) Metabolism of chylomicron-like emulsions in patients with Hodgkin’s and with non-Hodgkin’s lymphoma. Leuk Res 27: 147–53

    Article  PubMed  CAS  Google Scholar 

  15. Baker N, Gan-Elepano M, Guthrie BA, Mead JF (1989) Turnover and fate of plasma free fatty acids in briefly-fasted lymphoma-bearing mice. Lipids 24: 1028–34

    Article  PubMed  CAS  Google Scholar 

  16. Eagle DA, Gian V, Lauwers GY, et al. (2001) Gastroparesis following bone marrow transplantation. Bone Marrow Transplant 28: 59–62

    Article  PubMed  CAS  Google Scholar 

  17. Wolford JL, McDonald GB (1988) A problem-oriented approach to intestinal and liver disease after marrow transplantation. J Clin Gastroenterol 10 (4): 419–433

    Article  PubMed  CAS  Google Scholar 

  18. Keenan AM (1989) Nutritional support of the bone marrow transplant patient. Nurs Clin North Am 24: 383–93

    PubMed  CAS  Google Scholar 

  19. Grigg AP, Angus PV, Hoyt R, Szer J (2003) The incidence, pathogenesis and natural history of steatorrhea after bone marrow transplantation. Bone Marrow Transplant 31: 701–3

    Article  PubMed  CAS  Google Scholar 

  20. Cox GJ, Matsui SM, Lo RS, et al. (1994) Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 107: 1398–1407

    PubMed  CAS  Google Scholar 

  21. Jacobsohn DA, Margolis J, Doherty J, et al. (2002) Weight loss and malnutrition in patients with chronic graft-versus-host disease. Bone Marrow Transplant 29: 231–6

    Article  PubMed  CAS  Google Scholar 

  22. June CH, Thompson CB, Kennedy MS, et al. (1985) Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 39: 620–4

    Article  PubMed  CAS  Google Scholar 

  23. Antila HM, Salo MS, Kirvela O, et al. (1992) Serum trace element concentrations and iron metabolism in allogeneic bone marrow transplant recipients. Ann Med 24: 55–9

    Article  PubMed  CAS  Google Scholar 

  24. Carlin A, Walker WA (1991) Rapid development of vitamin K deficiency in an adolescent boy receiving total parenteral nutrition following bone marrow transplantion. Nutr Rev 49: 179–83

    Article  PubMed  CAS  Google Scholar 

  25. Jonas CR, Puckett AB, Jones DP, et al. (2000) Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72: 181–89

    PubMed  CAS  Google Scholar 

  26. Szeluga DJ, Stuart RK, Brookmeyer R, et al. (1985) Energy requirements of parenterally fed bone marrow transplant recipients. J Parenter Enteral Nutr 9: 139–143

    Article  CAS  Google Scholar 

  27. Cheney CL, Abson KG, Aker SN, et al. (1987) Body composition changes in marrow transplant recipients receiving total parenteral nutrition. Cancer 59: 1515–19

    Article  PubMed  CAS  Google Scholar 

  28. Schouten HC, Maragos D, Vose J, Armitage JO (1990) Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation. Bone Marrow Transplant 6: 333–5

    PubMed  CAS  Google Scholar 

  29. Smedmyr B, Wibell L, Simonsson B, Oberg G (1990) Impaired glucose tolerance after autologous bone marrow transplantation. Bone Marrow Transplant 6: 89–92

    PubMed  CAS  Google Scholar 

  30. Nemunaitis J, Deeg HJ, Yee GC (1986) High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia. Lancet 2: 744–5

    Article  PubMed  CAS  Google Scholar 

  31. Carreras E, Villamor N, Reverter JC, et al. (1989) Hypertriglyceridemia in bone marrow transplant recipients: another side effect of cyclosporine A. Bone Marrow Transplant 4: 385–388

    PubMed  CAS  Google Scholar 

  32. Hutchinson ML, Clemans GW, Springmeyer SC, Flournoy N (1984) Energy expenditure estimation of recipients of marrow transplants. Cancer 54: 1734–8

    Article  PubMed  CAS  Google Scholar 

  33. Annis K (1986) Measured energy expenditure in bone marrow transplant patients. JPEN J Parenter Enteral Nutr 15 (suppl): 34S

    Google Scholar 

  34. Ringwald-Smith K, Williams R, Horwitz E, et al. (1998) Determination of energy expenditure in the bone marrow transplant patient. Nutr Clin Pract 13: 215–8

    Google Scholar 

  35. Chamouard Cogoluenhes V, Chambrier C, Michallet M, et al. (1998) Energy expenditure during allogeneic and autologous bone marrow transplantation. Clin Nutr 17: 253–257

    Article  PubMed  CAS  Google Scholar 

  36. Taveroff A, McArdle AH, Rybka WB (1991) Reducing parenteral energy and protein intake improves metabolic homeostasis after bone marrow transplantation. Am J Clin Nutr 54: 1087–92

    PubMed  CAS  Google Scholar 

  37. Lenssen P, Bruemmer BA, Bowden RA, et al. (1998) Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr 67: 927–33

    PubMed  CAS  Google Scholar 

  38. Muscaritoli M, Conversano L, Torelli GF, et al. (1998) Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogenic bone marrow transplantation. Transplantation 66: 610–6

    Article  PubMed  CAS  Google Scholar 

  39. Santos P, Lourenco R, Camilo ME, et al. (2001) Parenteral nutrition and cyclosporine: do lipids make a difference? A prospective randomized crossover trial. Clin Nutr 20: 31–6

    Article  PubMed  CAS  Google Scholar 

  40. Roberts I, Miller JE, Pineiro LA (2000) Is total parenteral nutrition beneficial in breast cancer after analogous marrow or blood transplantation? J Parenter Enteral Nutr 24 (suppl): S11

    Google Scholar 

  41. Weisdorf SA, Lysne J, Wind D, et al. (1987) Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 43: 833–8

    PubMed  CAS  Google Scholar 

  42. Stern JM, Bruemmer B, Moinpour CM, et al. (2000) Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants. J Am Diet Assoc 100: 1015–22

    Article  PubMed  CAS  Google Scholar 

  43. Charuhas PM, Fosberg KL, Bruemmer B, et al. (1997) A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. JPEN J Parenter Enteral Nutr 21: 157–61

    PubMed  CAS  Google Scholar 

  44. Ziegler TR, Bye RL, Persinger RL, et al. (1998) Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci 315: 4–10

    Article  PubMed  CAS  Google Scholar 

  45. Piccirillo N, De Matteis S, Laurenti L, et al. (2003) Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica 88: 192–200

    PubMed  CAS  Google Scholar 

  46. Scheltinga MR, Young LS, Benfell K, et al. (1991) Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress. Ann Surg 4: 385–93

    Article  Google Scholar 

  47. Schloerb PR, Amare M (1993) Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 17: 407–13

    PubMed  CAS  Google Scholar 

  48. Ziegler TR, Young LS, Benfell K, et al. (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116: 821–8

    PubMed  CAS  Google Scholar 

  49. Schloerb PR, Skikne BS (1999) Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN J Parenter Enteral Nutr 23: 117–22

    PubMed  CAS  Google Scholar 

  50. van Zaanen HC, van der Lelie H, Timmer JG, et al. (1994). Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 74: 2879–84

    Article  PubMed  Google Scholar 

  51. Scheid C, Hermann K, Kremer G, et al. (2004) Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia under-going intensive chemotherapy. Nutrition 20: 249–54

    Article  PubMed  CAS  Google Scholar 

  52. Takastuka H, Takemoto Y, Iwata N, et al. (2001) Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 28: 769–74

    Article  Google Scholar 

  53. Takastuka H, Takemoto Y, Yamada S, et al. (2002) Oral eicosapentenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation. Drug Exp Clin Res 28: 121–5

    Google Scholar 

  54. Bendhamane B, Brandes I, Bhouris JH, et al. (1995) A comparison of medium-chain and long-chain triglycerides after bone marrow transplantation (BMT). International Symposium of Intensive Care and Emergency Medecine. March 21–24

    Google Scholar 

  55. Jimenez Jimenez FJ, Ortiz LC, Garcia Garmendia JL, et al. (1999) Prospective comparative study of different amino acid and lipid solutions in parenteral nutrition of patients undergoing bone marrow transplantation. Nutr Hosp 14: 57–66

    PubMed  CAS  Google Scholar 

  56. Demirer S, Aydintug S, Ustun C, et al. (2000) Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation. Clin Nutr 19: 253–258

    Article  PubMed  CAS  Google Scholar 

  57. Lenssen P, Cheney CL, Aker SN, et al. (1987) Intravenous branched chain amino acid trial in marrow transplant recipients. J Parenter Enteral Nutr 11: 112–8

    CAS  Google Scholar 

  58. Papadopoulou A, MacDonald A, Williams MD et al. (1997) Enteral nutrition after bone marrow transplantation. Arch Dis Child 77: 131–7

    PubMed  CAS  Google Scholar 

  59. Hopman GD, Peñna EG, le Cessie S, et al. (2003) Tube feeding and bone marrow transplantation. Med Pediatr Oncol 40: 375–9

    Article  PubMed  CAS  Google Scholar 

  60. Szeluga DJ, Stuart RK, Brookmeyer R, et al. (1987) Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 47 3309–16

    PubMed  CAS  Google Scholar 

  61. Sefcick A, Anderton D, Byrne JL, et al. (2001) Naso-jejunal feeding in allogenic bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant 28: 1135–9

    Article  PubMed  CAS  Google Scholar 

  62. Seguy D, Micol JB, Berthon C, et al. (2003) Influence de la nutrition entérale précoce chez les allogreffés. Nutr Clin Metabol 17 (suppl 1): 33s

    Google Scholar 

  63. Roberts SR, Miller JE (1998) Success using PEG tubes in marrow transplant recipient. Nutr Clin Pract 13: 74–8

    Article  Google Scholar 

  64. Sudre AC, Delarue R, Poisson-Salomon AS, et al. (2002) Evaluation des apports nutritionnels dans une unité de soins intensifs ďhématologie: impact ďun formulaire de nutrition thérapeutique. Nutr Clin Metabol 16 (suppl 1): 13s

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Raynard, B. (2007). Nutrition et hémopathies malignes. In: Traité de nutrition artificielle de l’adulte. Springer, Paris. https://doi.org/10.1007/978-2-287-33475-7_58

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-33475-7_58

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-33474-0

  • Online ISBN: 978-2-287-33475-7

Publish with us

Policies and ethics